NATALIZUMAB
UNII 3JB47N2Q2P

Substance Identification & Data

This profile provides standardized clinical and technical data for Natalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3JB47N2Q2P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 189261-10-7 and the RxNorm Concept ID (RxCUI) 354770. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3JB47N2Q2P

CAS Registry Number

189261-10-7

RxNorm Concept ID

354770

Detailed Substance Profile

Preferred Name

NATALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

3JB47N2Q2P

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C77862

National Cancer Institute reference terminology for clinical and research data.

INN ID

7716

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

II-90

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Natalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.